Treatment Adherance
September 6, 2011
TAG Excalibur Awards ’11
September 12, 2011
Show all

Special Presentation: Israel’s Nobel Laureate Aaron Ciechanover


Invite you to a special presentation


Israel’s Nobel Laureate

Aaron Ciechanover

Cancer and Vascular Biology Research Center, Faculty of Medicine Technion-Israel Institute of Technology

“Drug Development in the 21st Century – Are We Going to Cure all Diseases?”

Tuesday, October 4, 2011, 6:30 PM

Georgia Tech College of Management

800 West Peachtree Street NW

Atlanta, GA 30308 (DIRECTIONS)

No charge to attend, but please RSVP to

A native of Haifa, Professor Ciechanover received his Master of Science in 1970 and his M.D. in 1975 from the Hadassah Medical School of the Hebrew University in Jerusalem. He received his doctorate in medicine in 1981 from the Technion, and has been a Distinguished Research Professor at the Center for Cancer and Vascular Biology and the Director of the Rappaport Family Institute for Research in Medical Sciences at the Technion.

In 2004, he shared the Nobel Prize for Chemistry with Professor Avram Hershko and Professor Irwin Rose for the discovery of ubiquitin-mediated protein degradation, a mechanism by which the cells of most living organisms cull unwanted proteins. Besides being awarded the Nobel Prize, Professor Ciechanover shared the pretigious Albert Lasker Award for Basic Medical Research, the second most prestigious prize in life sciences and medicine, and the Israel Prize, the highest recognition bestowed by the State of Israel. Among many esteemed bodies, he is a member of the Israeli National Academy of Sciences and Humanities, the Pontifical Academy of Sciences of the Vatican and the American Philosophical Society.

Supported by:


Comments are closed.